Amiloidózis: nyitott vizsgálatok itt: Ausztrália
10 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Adelaide, Box Hill, Cairns, Garran, Melbourne, Perth, Westmead, Woolloongabba
- Age
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629EU 2023-507220-23-00Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- Where
- Adelaide, Box Hill, Fitzroy, Frankston, Westmead, Woolloongabba
- Age
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07224672EU 2025-522803-60-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Adelaide, Clayton, Darlinghurst, Hobart, Joondalup, Liverpool, Melbourne, Murdoch, Westmead, Woolloongabba
- Age
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Adelaide, Bedford Park, Box Hill, Chermside, Darlinghurst, Joondalup, Liverpool, Westmead
- Age
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903EU 2024-519917-72-00Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Darlinghurst, Woolloongabba
- Age
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203EU 2025-522544-40-00Regiszter frissítve: 2026-10-08
1. fázisToborozTrial-stage medicine
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
- Where
- Clayton, Fitzroy, Melbourne, Waratah, Wollongong
- Age
- 18 év and over
- People
- 276 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06768489EU 2024-515316-44-00Regiszter frissítve: 2026-09-25
3. fázisToborzás még nem indultTrial-stage medicine
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Bedford Park, Box Hill, Brisbane, Darlinghurst, Joondalup, Melbourne, Westmead
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483EU 2026-526755-57-00Regiszter frissítve: 2026-08-28
3. fázisToborozTrial-stage medicine
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Where
- Darlinghurst, Murdoch, Westmead, Woolloongabba
- Age
- 18 év to 75 év
- People
- 587 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895EU 2024-513547-82-00Regiszter frissítve: 2026-08-04
1/2. fázisToborozTrial-stage medicine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Where
- Box Hill, Westmead, Woolloongabba
- Age
- 18 év and over
- People
- 76 worldwide
- Run by
- AbbVie
See details and how to joinNCT06158854EU 2023-503429-20-00Regiszter frissítve: 2026-05-13
3. fázisCsak meghívásosTrial-stage medicine
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Where
- Clayton, Hobart, Joondalup, Leabrook, Liverpool, Murdoch, Westmead, Woolloongabba
- Age
- 18 év and over
- People
- 1400 worldwide
- Run by
- Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493Regiszter frissítve: 2026-04-17
Minden vizsgálat (Amiloidózis) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.